Seguici su acebook facebook Cerca nel sito:

Le ricerche di Gerona 2005

(27-03-14) Testing your levels of cardiovascular inflammation


by Dr. David Jockers

(NaturalNews) Most doctors have been misled to focus on total cholesterol as a key figure in measuring heart disease. More recent research has shown that measuring inflammatory mediators and inflammatory levels in the body is a much better way of assessing cardiovascular risk. C-reactive protein (CRP) is one of the major inflammatory markers that should be measured when assessing inflammatory levels and risk of heart disease.

CRP is released from the liver in response to acute tissue damage and inflammation. It is activated by macrophages and adipocytes to bind to phosphocholine expressed on the surface of dead or dying cells in order to activate the complement part of the immune system through the C1q complex. This means that it helps drive up inflammatory activity in the body.


Cardiovascular disease is an inflammation-mediated disorder:
Heart disease is characterized by chronic inflammatory activity in the cardiac tissue and major arterial beds of the body. This chronic inflammation causes scar tissue and plaque to build up in the arterioles as well as blood clotting to form. Over time, this leads to myocardial and cerebral infarctions. Studies have indicated that individuals with elevated levels of CRP have a risk about two to three times higher than the risk of those with low levels.

Over a dozen major studies have linked apparently healthy men and women and their future risk of cardiovascular events with higher levels of CRP. It has also been shown that CRP levels predict the risk of recurrent coronary events among patients who already have cardiovascular disease. The most important use of CRP is in detecting risk among individuals who do not know that they have a problem.


CRP and metabolic disease:
Individuals with CRP levels greater than 3 mg/L have a four to six times higher risk of developing diabetes than individuals with lower levels of CRP. This is another indication of the link connecting chronic inflammation to diabetes, obesity and heart disease. Many physicians include CRP levels in the diagnostic criteria for metabolic syndrome.

We used to think that obesity was solely related to eating too much and moving too little. Now, we understand that obesity is a condition characterized by chronic inflammatory activity in the body. Excess fat tissue is not dormant and metabolically inactive. It is constantly promoting the release of pro-inflammatory proteins and chemicals. The fat tissue itself actively contributes to the inflammatory processes. This creates a vicious cycle within the body that makes it more challenging for these individuals to get well.


Best cardiovascular panels:
It is very advantageous to look at CRP along with a number of other risk factors for cardiovascular disease. These include things like homocysteine and lipoprotein(a) as well as a basic lipid panel. More advanced panels will include a vertical auto profile (VAP) test that looks in much more detail at the lipid subtypes, as does the NMR (nuclear magnetic resonance) lipid profile.


Normal vs. pathological CRP ranges:
The key test for CRP levels is a "high sensitivity" test called hs-CRP. The standard CRP test does not have the ability to measure levels accurately within the range needed for cardiac risk detection. Normal ranges are considered to be under 3 mg/L. Healthy functional ranges are under 2 mg/L. If one has an active infection or tissue trauma, they will have higher hs-CRP levels and the test should be run again when the trauma or infection has been healed.

High-sensitivity CRP is usually ordered as one of several tests in a cardiovascular risk profile, often along with tests for cholesterol and triglycerides, when a person's risk of heart disease is being evaluated. Some experts say that the best way to predict risk is to combine a good marker for inflammation, like hs-CRP, with the lipid profile. When hs-CRP is evaluated, tests may be repeated to confirm that a person has persistent low levels of inflammation.

Sources for this article include:

http://circ.ahajournals.org

http://www.ncbi.nlm.nih.gov

http://labtestsonline.org

http://science.naturalnews.com

News

  • (30-08-2018) The electronics in fluorescent bulbs and light emitting diodes (LED), rather than ultraviolet radiation, cause increased malignant melanoma incidence in indoor office workers and tanning bed users

    Leggi tutto

  • (30-08-2018) Mitocondri e peso forma

    Leggi tutto

  • (29-08-2018) Stroke now impacting younger patients as a result of the obesity epidemic; 4 in 10 are now aged 40-69

    Leggi tutto

  • (29-08-2018) Perdere peso non vuol dire perdere osso!

    Leggi tutto

  • (29-08-2018) Brain cholesterol: long secret life behind a barrier.

    Leggi tutto

  • (29-08-2018) Stile di vita sano? Si può, basta usare la fantasia

    Leggi tutto

  • (22-08-2018) Top 10 medical treatments that can make you SICKER than before you took them

    Leggi tutto

  • (22-08-2018) Meno ansia - C’è una associazione tra dieta e disturbi mentali?

    Leggi tutto

  • (22-08-2018) Dietary curcumin supplementation attenuates inflammation, hepatic injury and oxidative damage in a rat model of intra-uterine growth retardation.

    Leggi tutto

  • (22-08-2018) Dopo la gravidanza - Una dieta a basso indice glicemico se serve perdere peso

    Leggi tutto

  • (21-08-2018) Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

    Leggi tutto

  • (21-08-2018) Anche i neo-papà soffrono della depressione post partum

    Leggi tutto


In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.

Informazioni utili